Survival and safety of exemestane versus tamoxifen after 2–3 years' tamoxifen treatment (Intergroup Exemestane Study): a randomised controlled trial.Erratum - Coombes,R.C.; Kilburn,L.S.; Snowdon,C.F. (LancetLancet, 2007)